[ASAP] Theranostic Surrogacy of [123I]NaI for Differentiated Thyroid Cancer Radionuclide Therapy 🔗 Access full article via ACS Molecular Pharmaceutics The study of chemical pharmacyDOI: 10.1021 / acs. Molpharmaceut. 3c00073. Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
